» Articles » PMID: 36266982

Nanomedicine-Enabled/Augmented Cell Pyroptosis for Efficient Tumor Nanotherapy

Overview
Journal Adv Sci (Weinh)
Date 2022 Oct 21
PMID 36266982
Authors
Affiliations
Soon will be listed here.
Abstract

The terrible morbidity and mortality of malignant tumors urgently require innovative therapeutics, especially for apoptosis-resistant tumors. Pyroptosis, a pro-inflammatory form of programmed cell death (PCD), is featured with pore formation in plasma membrane, cell swelling with giant bubbles, and leakage of cytoplasmic pro-inflammatory cytokines, which can remodel the tumor immune microenvironment by stimulating a "cold" tumor microenvironment to be an immunogenic "hot" tumor microenvironment, and consequently augment the therapeutic efficiency of malignant tumors. Benefiting from current advances in nanotechnology, nanomedicine is extensively applied to potentiate, enable, and augment pyroptosis for enhancing cancer-therapeutic efficacy and specificity. This review provides a concentrated summary and discussion of the most recent progress achieved in this emerging field, highlighting the nanomedicine-enabled/augmented specific pyroptosis strategy for favoring the construction of next-generation nanomedicines to efficiently induce PCD. It is highly expected that the further clinical translation of nanomedicine can be accelerated by inducing pyroptotic cell death based on bioactive nanomedicines.

Citing Articles

Donor modulation brings all-in-one phototheranostics for NIR-II imaging-guided type-I photodynamic/photothermal synergistic cancer therapy.

Ren Y, Zhang X, Li L, Yuan Q, Bao B, Li M Chem Sci. 2025; .

PMID: 39968281 PMC: 11831688. DOI: 10.1039/d4sc08685f.


FDA-Approved Hydrogel-Mediated In Situ Sonodynamic and Chemotherapeutic Therapy for Pancreatic Cancer.

Wang J, Yu N, Tang Y, Cheng Y, Li H Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770508 PMC: 11678859. DOI: 10.3390/ph17121666.


Arming oncolytic M1 virus with gasdermin E enhances antitumor efficacy in breast cancer.

Chen X, Liu Y, Zhu W, Li S, Wei S, Cai J iScience. 2024; 27(11):111148.

PMID: 39555415 PMC: 11565026. DOI: 10.1016/j.isci.2024.111148.


Oxygen-carrying semiconducting polymer nanoprodrugs induce sono-pyroptosis for deep-tissue tumor treatment.

Wang F, Fan Y, Liu Y, Lou X, Sutrisno L, Peng S Exploration (Beijing). 2024; 4(4):20230100.

PMID: 39175882 PMC: 11335461. DOI: 10.1002/EXP.20230100.


Nanoparticle-mediated cell pyroptosis: a new therapeutic strategy for inflammatory diseases and cancer.

Zhao L, Cheng H, Tong Z, Cai J J Nanobiotechnology. 2024; 22(1):504.

PMID: 39175020 PMC: 11340130. DOI: 10.1186/s12951-024-02763-3.


References
1.
Chen X, Gambhir S, Cheon J . Theranostic nanomedicine. Acc Chem Res. 2011; 44(10):841. DOI: 10.1021/ar200231d. View

2.
Taabazuing C, Okondo M, Bachovchin D . Pyroptosis and Apoptosis Pathways Engage in Bidirectional Crosstalk in Monocytes and Macrophages. Cell Chem Biol. 2017; 24(4):507-514.e4. PMC: 5467448. DOI: 10.1016/j.chembiol.2017.03.009. View

3.
Hu J, Dong Y, Ding L, Dong Y, Wu Z, Wang W . Local delivery of arsenic trioxide nanoparticles for hepatocellular carcinoma treatment. Signal Transduct Target Ther. 2019; 4:28. PMC: 6799825. DOI: 10.1038/s41392-019-0062-9. View

4.
Zhang Y, Sha R, Zhang L, Zhang W, Jin P, Xu W . Harnessing copper-palladium alloy tetrapod nanoparticle-induced pro-survival autophagy for optimized photothermal therapy of drug-resistant cancer. Nat Commun. 2018; 9(1):4236. PMC: 6185906. DOI: 10.1038/s41467-018-06529-y. View

5.
Cookson B, Brennan M . Pro-inflammatory programmed cell death. Trends Microbiol. 2001; 9(3):113-4. DOI: 10.1016/s0966-842x(00)01936-3. View